Hepatitis C virus quasispecies in chronically infected children subjected to interferon-ribavirin therapy

Arch Virol. 2010 Dec;155(12):1977-87. doi: 10.1007/s00705-010-0789-7. Epub 2010 Sep 15.

Abstract

Accumulating evidence suggests that certain features of hepatitis C virus (HCV), especially its high genetic variability, might be responsible for the low efficiency of anti-HCV treatment. Here, we present a bioinformatic analysis of HCV-1a populations isolated from 23 children with chronic hepatitis C (CHC) subjected to interferon-ribavirin therapy. The structures of the viral quasispecies were established based on a 132-amino-acid sequence derived from E1/E2 protein, including hypervariable region 1 (HVR1). Two types of HCV populations were identified. The first type, found in non-responders, contained a small number of closely related variants. The second type, characteristic for sustained responders, was composed of a large number of distantly associated equal-rank variants. Comparison of 445 HVR1 sequences showed that a significant number of variants present in non-responding patients are closely related, suggesting that certain, still unidentified properties of the pathogen may be key factors determining the result of CHC treatment.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Antiviral Agents / therapeutic use*
  • Child
  • Cluster Analysis
  • DNA, Viral / chemistry
  • DNA, Viral / genetics
  • Female
  • Genotype
  • Hepacivirus / classification*
  • Hepacivirus / genetics
  • Hepacivirus / isolation & purification
  • Hepatitis C, Chronic / drug therapy*
  • Hepatitis C, Chronic / virology*
  • Humans
  • Interferon alpha-2
  • Interferon-alpha / therapeutic use*
  • Male
  • Polymorphism, Genetic*
  • Recombinant Proteins
  • Ribavirin / therapeutic use*
  • Sequence Analysis, DNA
  • Sequence Homology
  • Viral Envelope Proteins / genetics

Substances

  • Antiviral Agents
  • DNA, Viral
  • E1 protein, Hepatitis C virus
  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins
  • Viral Envelope Proteins
  • glycoprotein E2, Hepatitis C virus
  • Ribavirin